Beskrivning
| Land | Norge |
|---|---|
| Lista | Euronext Growth Oslo |
| Sektor | Informationsteknik |
| Industri | Programvara |
Reference is made to the stock exchange announcement on 30 November 2023, where Nordhealth AS (the "Company") launched an offer to purchase up to 1,000,000 of its own shares through a reverse book building process (the "Offering").
The application period expired at 16:30 hours (CET) on 6 December 2023. Following the end of the application period, the Company has resolved to buy 992,624 shares at a price of NOK 23.00 per share, which equals approximately NOK 22.8 million in total.
All offers to sell shares with limits at or below NOK 23.00 have been allocated in full.
Allocation notifications will be sent to shareholders having tendered shares in the Offering on or about 7 December 2023. The trade date is expected to be on or about 7 December 2023 and the settlement date is expected to be on or about 11 December 2023.
The settlement will be conducted on a normal delivery-versus-payment basis (DVP). Following settlement of the Offering, the Company will own 1,146,637 shares in the Company. The Company currently has 80,191,746 shares outstanding.